The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

A new FDA-approved drug brings in a lot of hope for men with aggressive prostate cancer, as it may increase their chances of survival by 40 per cent. According to experts, the combination of two drugs ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

Cancer survival rates have reached a record high, according to a new report from the American Cancer Society (ACS). The ...